Compare DTSS & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DTSS | VVOS |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0M | 9.7M |
| IPO Year | 2015 | 2020 |
| Metric | DTSS | VVOS |
|---|---|---|
| Price | $0.85 | $0.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | 37.0K | ★ 137.7K |
| Earning Date | 05-14-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 82.42 | 6.76 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $71,616,820.00 | $17,443,000.00 |
| Revenue This Year | N/A | $69.66 |
| Revenue Next Year | N/A | $48.38 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 198.70 | 16.05 |
| 52 Week Low | $0.64 | $0.55 |
| 52 Week High | $2.50 | $7.40 |
| Indicator | DTSS | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 41.92 | 40.93 |
| Support Level | $0.80 | $0.65 |
| Resistance Level | $0.98 | $0.77 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 15.75 | 58.52 |
Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.